Replimune Group, Inc. (REPL)
19.07
-0.16
(-0.83%)
USD |
NASDAQ |
Nov 20, 16:00
19.07
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Cash and Short Term Investments (Annual) : 268.89M for March 31, 2026
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| March 31, 2026 | 268.89M |
| March 31, 2025 | 483.80M |
| March 31, 2024 | 420.67M |
| March 31, 2023 | 583.39M |
| March 31, 2022 | 395.66M |
| Date | Value |
|---|---|
| March 31, 2021 | 476.30M |
| March 31, 2020 | 168.56M |
| March 31, 2019 | 134.81M |
| March 31, 2018 | 61.55M |
| March 31, 2017 | 20.59M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| PepGen Inc. | 148.46M |
| Oncolytics Biotech, Inc. | 5.202M |
| Sangamo Therapeutics, Inc. | 20.95M |
| Sarepta Therapeutics, Inc. | 939.65M |
| Anixa Biosciences, Inc. | 15.17M |